Intravenous and oral zidovudine pharmacokinetics and coagulation effects in asymptomatic human immunodeficiency virus-infected hemophilia patients.

Pharmacokinetic and coagulation studies were carried out over a 12-week period with 11 asymptomatic hemophilia patients with human immunodeficiency virus infection receiving zidovudine (ZDV). The patients received 300 mg every 4 h while awake (the accepted dose at the time of this study); consecutiv...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Antimicrob Agents Chemother
Autores principales: Morse, G D, Portmore, A C, Marder, V, Plank, C, Olson, J, Taylor, C, Bonnez, W, Reichman, R C
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology (ASM) 1992
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC245484/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1444306/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.10.2245
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares